Dr. Radhakrishnan Ramchandren, M.D.
Claim this profileUniversity of Tennessee
Studies Lymphoma
Studies Hodgkin's Lymphoma
7 reported clinical trials
13 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage IV
Stage III
2Hodgkin's Lymphoma
Stage I
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Radhakrishnan Ramchandren, M.D. is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
SGN-35T
for Lymphoma
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Recruiting1 award Phase 110 criteria
More about Radhakrishnan Ramchandren, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Radhakrishnan Ramchandren, M.D. has experience with
- Brentuximab Vedotin
- Doxorubicin
- Rituximab
- Lenalidomide
- Dacarbazine
- Nivolumab
Breakdown of trials Radhakrishnan Ramchandren, M.D. has run
Lymphoma
Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Peripheral T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Radhakrishnan Ramchandren, M.D. specialize in?
Radhakrishnan Ramchandren, M.D. focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage IV.
Is Radhakrishnan Ramchandren, M.D. currently recruiting for clinical trials?
Yes, Radhakrishnan Ramchandren, M.D. is currently recruiting for 3 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Radhakrishnan Ramchandren, M.D. has studied deeply?
Yes, Radhakrishnan Ramchandren, M.D. has studied treatments such as Brentuximab Vedotin, Doxorubicin, Rituximab.
What is the best way to schedule an appointment with Radhakrishnan Ramchandren, M.D.?
Apply for one of the trials that Radhakrishnan Ramchandren, M.D. is conducting.
What is the office address of Radhakrishnan Ramchandren, M.D.?
The office of Radhakrishnan Ramchandren, M.D. is located at: University of Tennessee, Knoxville, Tennessee 37920 United States. This is the address for their practice at the University of Tennessee.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.